Daily Respiratory Research Analysis
Three papers stand out today: a droplet-based single-cell pairing platform (SPLIS) that maps library-on-library interactions between SARS-CoV-2 spike and human ACE2 variants; a multi-omics study showing lung microbiota state transitions that track and predict pneumonia progression; and a spectral fingerprint PCR method that enables high-plex detection, including respiratory pathogens, in homogeneous systems. Collectively, they advance precision infectious disease biology, microbiome-informed pne
Summary
Three papers stand out today: a droplet-based single-cell pairing platform (SPLIS) that maps library-on-library interactions between SARS-CoV-2 spike and human ACE2 variants; a multi-omics study showing lung microbiota state transitions that track and predict pneumonia progression; and a spectral fingerprint PCR method that enables high-plex detection, including respiratory pathogens, in homogeneous systems. Collectively, they advance precision infectious disease biology, microbiome-informed pneumonia care, and scalable diagnostics.
Research Themes
- High-throughput host–virus interaction mapping
- Lung microbiome dynamics in pneumonia
- Next-generation multiplex PCR diagnostics
Selected Articles
1. Droplet-based single-cell pairing for high-throughput interaction mapping of antigen-receptor combinations.
SPLIS deterministically pairs a single antigen-presenting cell with a single receptor-expressing cell in droplets to quantify syncytium formation across spike–ACE2 variant pairs. It reveals both fusion-enhancing and -inhibiting combinations and shows how ACE2 SNPs modulate susceptibility to emerging SARS-CoV-2 spike mutations.
Impact: This platform enables scalable, quantitative mapping of host–virus interaction landscapes and links human genetic variation to variant-specific viral fusion, informing susceptibility prediction and preparedness.
Clinical Implications: While preclinical, the approach can prioritize concerning spike mutations and host ACE2 variants for surveillance, guide variant risk assessment, and support precision public health strategies for respiratory virus threats.
Key Findings
- Developed SPLIS to deterministically co-encapsulate one sender and one receiver cell in droplets and read out fusion by sequencing fused DNA barcodes.
- High-throughput profiling identified spike–ACE2 variant pairs that enhance or inhibit syncytium formation.
- ACE2 single-nucleotide polymorphisms modulate susceptibility to emerging SARS-CoV-2 spike mutations.
Methodological Strengths
- Deterministic single-cell pairing via droplet sorting and merging enables controlled library-on-library screening.
- Sequencing-based fused DNA readouts provide scalable, quantitative interaction mapping.
Limitations
- Cell–cell fusion is a proxy for entry and may not fully capture multistep viral infection in vivo.
- Generalization to other receptor–ligand systems requires additional validation and engineering.
Future Directions: Extend SPLIS to other respiratory viruses and host receptors, integrate with CRISPR perturbations for causal mapping, and validate key variant pairs in physiologic airway models.
Mapping the interaction potential of different variant combinations of viral antigens and human cell receptors and understanding how viral antigen mutations interact with human genetic polymorphisms are critical for predicting infection susceptibility and informing precision public health strategies. Here, we develop a droplet-based single-cell pairing and library-on-library interaction screening (SPLIS) system for high-throughput profiling of the syncytium-formation landscapes of various spike-angiotensin-converting enzyme 2 (ACE2) variant combinations. This system uses combined droplet sorting and merging to deterministically encapsulate one antigen-presenting sender cell and one receptor-expressing receiver cell into each drop, followed by selection and sequencing of the fused DNA readouts to characterize the syncytium-formation potential of each combination. We applied SPLIS to characterize both fusion-enhancing and -inhibiting variant pairs, comprehensively profiling how ACE2 single-nucleotide polymorphisms modulate susceptibility to emerging severe acute respiratory syndrome coronavirus 2 spike mutations. Our system emerges as a powerful tool to interrogate the interactions between two libraries of variants, offering valuable insights into host susceptibility patterns and viral infectivity trends.
2. Transitions in lung microbiota landscape associate with distinct patterns of pneumonia progression.
Using integrated 16S, metagenomic, metatranscriptomic, and bacterial-load data from bronchoscopic samples, this study defines dynamic lung microbiota states that predict pneumonia subtypes and therapy responses. Aspiration emerges as a disruptive ecological force linked to coordinated shifts in microbial gene expression and community structure.
Impact: It links microbiome state transitions to clinical phenotypes and treatment response in pneumonia, opening routes for microbiome-informed stratification and management.
Clinical Implications: Microbiome state profiling could complement diagnostics to classify pneumonia subtypes, inform aspiration-targeted care, and anticipate therapy response, potentially optimizing antibiotics and supportive strategies.
Key Findings
- Integrated multi-omics and bacterial-load quantification delineated dynamic lung microbiota states across pneumonia course.
- Microbiota states predicted pneumonia subtypes and showed differential stability and therapy responses.
- Aspiration was associated with cohesive shifts in microbial gene expression and community structure.
Methodological Strengths
- Large bronchoscopic sample set with integrated 16S, metagenomic, metatranscriptomic, and quantitative bacterial-load measurements.
- State-based ecological modeling linking microbiota dynamics to clinical phenotypes and treatment response.
Limitations
- Observational design limits causal inference regarding microbiota changes and outcomes.
- External validation and standardized sampling under varying antibiotic exposures are needed.
Future Directions: Prospective validation of microbiome state classifiers, interventional studies targeting aspiration or dysbiosis, and integration with host omics to build actionable decision-support tools.
The precise microbial determinants driving clinical outcomes in severe pneumonia are unknown. Competing ecological forces produce dynamic microbiota states in health and disease, and a more thorough understanding of these states has the potential to improve pneumonia therapy. Here, we leverage a large collection of bronchoscopic samples from patients with suspected pneumonia to determine lung microbial ecosystem dynamics throughout the course of pneumonia. We combine 16S rRNA gene, metagenomic, and metatranscriptomic sequencing with bacterial-load quantification to reveal clinically relevant drivers of pneumonia progression. Microbiota states are predictive of pneumonia subtypes and exhibit differential stability and pneumonia therapy response. Disruptive forces, such as aspiration, are associated with cohesive changes in gene expression and microbial community structure. In summary, we show that host and microbiota landscapes change in unison with clinical phenotypes and that microbiota state dynamics reflect pneumonia progression. We suggest that distinct pathways of lung microbial community succession mediate pneumonia progression.
3. Spectral fingerprint diagnosis: Spatially independent analysis of biomarker patterns in homogeneous systems.
sf-PCR encodes three-dimensional fluorescence spectral fingerprints (peak position and intensity) to overcome spectral overlap in homogeneous multiplex PCR. A 10-plex model shows linear superimposability and decodability, with demonstrated potential in cancer and respiratory pathogen detection.
Impact: By fundamentally addressing spectral overlap without spatial barcoding, sf-PCR enables higher-plex homogeneous assays scalable to point-of-care respiratory diagnostics.
Clinical Implications: sf-PCR could streamline multiplex respiratory pathogen panels with fewer channels and simpler optics, supporting rapid syndromic testing in clinical and near-patient settings.
Key Findings
- Introduced spectral fingerprint PCR that uses 3D fluorescence fingerprints to resolve spectral overlap in homogeneous multiplex assays.
- Demonstrated linear superimposability and decodability in a 10-plex sf-PCR model.
- Showed clinical potential in cancer diagnostics and respiratory pathogen detection.
Methodological Strengths
- Spectral fingerprinting increases information density beyond traditional channel-limited multiplexing.
- Linear superimposability/decodability enhances interpretability and scalability.
Limitations
- Clinical validation breadth and head-to-head comparisons with gold-standard multiplex assays are limited in this report.
- Performance under complex clinical matrices and high target burden needs further assessment.
Future Directions: Benchmark sf-PCR against established multiplex respiratory panels across diverse specimen types, and integrate with portable optics for point-of-care deployment.
High-throughput biomarker analysis traditionally relies on spatial distribution features, either naturally occurring or artificially engineered. Achieving multiplex detection in a homogeneous system without spatial distribution remains a challenge. Fluorescence-based polymerase chain reaction (PCR) exemplifies a spatially independent technology for targeted multiplex detection, but it is limited by spectral overlap. Here, we proposed spectral fingerprint PCR (sf-PCR), which leverages three-dimensional fluorescence spectral fingerprints to profile biomarker expression patterns. These fingerprints capture both the position and intensity of fluorescence peaks, increasing information density and offering a breakthrough in spectral overlap. In addition, sf-PCR exhibits linear superimposability and decodability, providing a solid foundation for data interpretability. Using a 10-plex sf-PCR model, we demonstrated sf-PCR's capacity to fundamentally overcome spectral overlap limitations. Furthermore, sf-PCR has demonstrated clinical potential in cancer diagnosis and respiratory pathogen detection. This work underscores the potential of spectral fingerprints to enhance information density and fundamentally resolve challenges in homogeneous system analysis.